2-Imino-4-oxopyrrolo[2,3-d]pyrimidine-5-carbonitrile

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡咯并嘧啶类
• 英文名称: 2-Imino-4-oxopyrrolo[2,3-d]pyrimidine-5-carbonitrile
• 英文别名: 2-imino-4-oxopyrrolo[2,3-d]pyrimidine-5-carbonitrile
• 化学式: C₇H₃N₅O
• mdl: MFCD09878565
• 分子量: 173.13
• InChiKey: CXOHWJIYWYQKAT-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -1.4
• 重原子数：
  13
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  104
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  核苷Q 、 2-Imino-4-oxopyrrolo[2,3-d]pyrimidine-5-carbonitrile 、 吉非替尼中间体3 、 氯乙腈 、 甲酸甲酯 在 2-amino-4-oxo-5-cyanopyrrolo[2,3-d]pyrimidine(III) 作用下， 以Cyclocon-densation of compound 10 with 2,6-diamino-4-oxopyrimidine afforded to the key intermediate in 65-70% overall yield的产率得到
  参考文献：
  名称：

  Novel pyrimidine derivatives and methods of making and using these derivatives

  摘要：

  本发明揭示了嘧啶衍生物及其药学上可接受的盐和前药，用于治疗患有疾病的患者的治疗和/或预防。这些疾病包括癌症和免疫功能受损的患者中由Pneumocystis carinii和Toxoplasmosis gondii引起的继发感染。本发明还揭示了这些化合物本身，制备这些化合物的方法以及使用这些化合物的方法。

  公开号：

  US20040039000A1

文献信息

• Pyrimidine derivatives and methods of making and using these derivatives
  申请人：Gangjee Aleem

  公开号：US06962920B2

  公开（公告）日：2005-11-08

  This invention discloses pyrimidine derivatives, and pharmaceutically acceptable salts and prodrugs thereof, useful in therapeutically and/or prophylactically treating patients with an illness. Such illnesses include cancer, and secondary infections caused by Pneumocystis carinii and Toxoplasmosis gondii in immunocompromised patients. The compounds themselves, methods of making these compounds, and methods of using these compounds are all disclosed.

  本发明揭示了嘧啶衍生物、其药学上可接受的盐和前药，可用于治疗和/或预防患有疾病的患者。这些疾病包括癌症，以及由免疫系统受损的患者引起的Pneumocystis carinii和Toxoplasmosis gondii的继发性感染。本发明揭示了这些化合物本身、制备这些化合物的方法以及使用这些化合物的方法。
• Riboswitches and methods and compositions for use of and with riboswitches
  申请人：Yale University

  公开号：EP2426218A1

  公开（公告）日：2012-03-07

  Riboswitches are targets for antibiotics and other small molecule therapies. Riboswitches and portions thereof can be used to regulate the expression or function of RNA molecules and other elements and molecules. Riboswitches and portions thereof can be used in a variety of other methods to, for example, identify or detect compounds. Compounds can be used to stimulate, active, inhibit and/or inactivate the riboswitch. Riboswitches and portions thereof, both alone and in combination with other nucleic acids, can be used in a variety of constructs and RNA molecules and can be encoded by nucleic acids.

  核糖开关是抗生素和其他小分子疗法的靶标。核糖开关及其部分可用于调节 RNA 分子及其他元素和分子的表达或功能。核糖开关及其部分可用于多种其它方法，例如识别或检测化合物。化合物可用于刺激、激活、抑制和/或使核糖开关失活。核糖开关及其部分，无论是单独使用还是与其它核酸结合使用，都可用于各种构建物和 RNA 分子，并可由核酸编码。
• RIBOSWITCHES AND METHODS AND COMPOSITIONS FOR USE OF AND WITH RIBOSWITCHES
  申请人：Yale University

  公开号：EP2164996A2

  公开（公告）日：2010-03-24
• PREQ1 RIBOSWITCHES AND METHODS AND COMPOSITIONS FOR USE OF AND WITH PREQ1 RIBOSWITCHES
  申请人：Breaker Ronald R.

  公开号：US20100152212A1

  公开（公告）日：2010-06-17

  The preQ1 riboswitch is a target for antibiotics and other small molecule therapies. The preQ1riboswitch and portions thereof can be used to regulate the expression or function of RNA molecules and other elements and molecules. The preQ1 riboswitch and portions thereof can be used in a variety of other methods to, for example, identify or detect compounds. Compounds can be used to stimulate, active, inhibit and/or inactivate the preQ1 riboswitch. The preQ1 riboswitch and portions thereof, both alone and in combination with other nucleic acids, can be used in a variety of constructs and RNA molecules and can be encoded by nucleic acids.
• US6962920B2
  申请人：——

  公开号：US6962920B2

  公开（公告）日：2005-11-08